ArticleCancer research and treatment2026

DNA Damage and Nuclear Anaplasia Induced by Trastuzumab Deruxtecan in Cancer Cells with Variable HER2 Expression and Homologous Recombination Deficiency Status.

So Hyeon Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.